scholarly journals Weaning from Impella and mobilization of Impella patients

2021 ◽  
Vol 23 (Supplement_A) ◽  
pp. A41-A45
Author(s):  
Letizia Fausta Bertoldi ◽  
Andrea Montisci ◽  
Clement Delmas ◽  
Federico Pappalardo

Abstract Weaning of patients from Impella is complex and includes evaluation of the underlying disease, which is essential for estimating the potential for heart recovery. Monitoring during the weaning phase with echocardiography and pulmonary artery catheters will be discussed, as well as the use of intravenous and oral heart failure drugs. Patients who are candidates for weaning must be stable, without inotropes, and must have recovered from acute end-organ damage. Coronary artery disease and valvular heart diseases should be appropriately addressed before weaning to take the maximum advantage of haemodynamic stability provided by the support and to maximize the possibility of weaning. Tips and tricks for the mobilization of Impella patients will also be discussed.

Author(s):  
MARIAM AHMED ◽  
HANA MORRISSEY ◽  
PATRICK ANTHONY BALL

Objective: To establish if depression results in poor adherence to therapy in patients with heart diseases. Methods: This concept scoping study was conducted in two phases; the first was a systematic review of the literature, and the second part was local data analysis. Statistical analysis was performed using RevMan® V.5.3 (Cochrane Community). Results: Patients who received multidisciplinary collaborative care showed significantly reduced major adverse cardiac outcomes in patients with cardiovascular diseases. They also demonstrated higher rates of self-reported remission of depression. The review also showed endpoint mortality after PCI was associated with patients having depression. Local population data showed that 26% of heart failure patients had mental ill health comorbidity, however, only 12% had a formal diagnosis recorded. Conclusion: Depression is associated with poor cardiac outcomes in patients with coronary artery disease. It is widespread in patients with cardiovascular disease and must be screened for throughout the management plan.


2009 ◽  
Vol 73 (11) ◽  
pp. 2148-2153 ◽  
Author(s):  
Hidetoshi Abe ◽  
Masafumi Takahashi ◽  
Hironobu Yaegashi ◽  
Seiichiro Eda ◽  
Hiroto Kitahara ◽  
...  

2013 ◽  
Vol 5 (2) ◽  
Author(s):  
Michael S. Kawilarang ◽  
Iman Y. Suhartono ◽  
Elfan Moeljono ◽  
Loretta C. Wangko ◽  
Agnes L. Panda ◽  
...  

Abstrak: Fibrilasi atrial merupakan gangguan irama jantung menetap yang paling sering dijumpai di praktek sehari-hari, ditandai oleh adanya aktivasi atrium yang tidak terorganisasi dan kontraksi atrium dan ventrikel yang tidak terkoodinasi. Meskipun banyak laporan mengenai fibrilasi atrial di Indonesia, tetapi hal ini belum pernah dilaporkan di Sulawesi Utara. Penelitian ini bertujuan untuk mendapatkan profil fibrilasi atrial di Manado. Data diambil dari pasien fibrilasi atrial di Bagian Jantung dan Pembuluh Darah, Prof R D Kandou, Manado, sejak September 2012-Februari 2013. Variabel yang diamati ialah jenis kelamin, usia, penyakit penyerta, ekokardiografi, dan terapi. Sebanyak 84 pasien diikutsertakan dalam penelitian ini, terdiri dari 42 laki-laki dan 42 perempuan dengan usia 21-84 tahun dengan rincian 53 pasien berusia ≥60 tahun dan 30 pasien <60 tahun. Pada 59 pasien yang dilakukan ekokardiografi, 39 pasien (66,1%) mempunyai fraksi ejeksi ≥55%; dan 20 pasien (33,9%) <55% (rerata 55,8%). Pembesaran atrium kiri ditemukan pada 33 pasien (55,9%) dan trombus pada 13 pasien (22%). Penyakit penyerta yang ditemukan ialah: hipertensi pada 35 pasien (41,7%); gagal jantung 40 pasien (40,76%); penyakit jantung koroner 20 pasien (23,8%); penyakit jantung katub 21 pasien (25%); penyakit paru 6 pasien (7%); hipertiroid 5 pasien (6%); dan tanpa penyakit penyerta 1 pasien (1,2%). Pada 70 pasien (83,3%) diberikan terapi bisoprolol; 2 pasien (2,4%) digoksin; 3 pasien (3,5%) amiodaron; 7 pasien (8,4%) bisoprolol dan digoksin; dan 2 (2,4%) bisoprolol dan amiodaron. Obat antikoagulan oral diberikan pada 28 pasien (33,03%), dan aspirin pada 40 pasien (47,6%). Stroke ditemukan pada 4 pasien (4,8%); satu orang diantaranya meninggal akibat stroke. Simpulan: Fibrilasi atrial lebih sering ditemukan pada usia lanjut. Gagal jantung dan hipertensi merupakan penyakit penyerta yang tersering, sehingga perlu diwaspadai. Bisoprolol merupakan pilihan terapi yang tersering diberikan, dan angka komplikasi dan kematiannya rendah. Kata kunci: fibrilasi atrial, penyakit penyerta, terapi.   Abstract: Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia encountered in clinical practice characterized by disorganized atrial activation and uncoordinated contraction of the atria and ventricle. Although there are many reports regarding the profile of atrial fibrillation (AF) in Indonesia, none have been published in North Sulawesi. This study aimed to provide epidemiological data regarding atrial fibrillation profile in Manado. We reviewed medical records of outpatients diagnosed with AF in the Department of Cardiology and Vascular Medicine, Prof. Dr. R.D. Kandou Hospital, Manado, from September 2012-February 2013. Relevant variables such as gender, age, co-morbids, echocardiography, and medical therapy were documented. The results showed that a total of 84 patients with AF were enrolled in the study. There were 42 males (50%) and 42 females (50%) with age ranges from 21 to 84 years (mean 60.74 years), of these 53 patients (63%) were ≥60 years and 31 patients (37%) <60 years. From the total 84 patients, 59 patients underwent echocardiography examinations: 39 patients (66.1%) had ejection fraction (EF) ≥55%; and 20 patients (33.9%) had EF <55% (mean 55.8%). Left atrial enlargement was found in 33 patients (55.9%) and thrombus was found in 13 patients (22%). Besides suffering from AF, 35 patients (41.7%) had hypertension, 40 (40.76%) had congestive heart failure, 20 (23.8%) had coronary artery disease, 21 (25%) had valvular heart diseases, 6 (7%) had pulmonary diseases, 5 (6%) had hyperthyroidism, and 1 (1.2%)  had no comorbid. Seventy patients (83.3%) were treated with bisoprolol, 2 (2.4%) with digoxin, 3 (3.5%) with amiodarone, 7 (8.4%) with bisoprolol and digoxin, and 2 (2.4%) with bisoprolol and amiodarone. Oral anticoagulant was used in 28 patients (33.3%), and aspirin in 40 patients (47.6%). Strokes were found in four patients (4.8%); one died due to stroke. Conclusion: The prevalence of AF was higher in the elderly. Congestive heart failure and hypertension were the most common co-morbids found, thus, greater awareness is needed. Bisoprolol was used as the highest proportion of treatment in AF patients, and the complication and mortality rates were low. Keywords: atrial fibrillation, comorbids, therapy.


2019 ◽  
Vol 4 (1) ◽  
pp. 81-86
Author(s):  
Natalia N. Petrova

Background.Today the prevalence of mental disorders have grown significantly, so it is urgent to diagnose and correct them as early as possible. Mental disorders in patients with cardiovascular diseases aggravate the course and outcomes of the underlying disease, which necessitates their investigation in clinical practice.Aim:to study the frequency and phenomenology of mental disorders in patients with cardiovascular diseases.Materials and methods.Sixty patients of the Cardiology Department of St. Petersburg Multidisciplinary Hospital became the objects of the study, and comprised 2 groups. The first group included 30 patients with cardiovascular diseases, such as coronary artery disease and hypertension I–III stages, among them 10 men and 20 women aged 43.1 ± 11.7 years. The second group consisted of 30 patients with chronic heart failure in stabilization period (mean age 65.6 ± 10.8 years). The study included clinical and scale assessment.Results.We found that in patients with cardiovascular diseases mild disorders of affective spectrum prevail, with a typical comorbidity of anxiety and depression. Mental disorders and personal features in patients with chronic heart failure are different from those in patients with uncomplicated cardiovascular conditions. Mental disorders are detected in cardiological practice only in one third of patients, which reveals the problem of training internists, who could diagnose the most common mental disorders.Conclusions.Complex clinical and scale assessment in combination with the results of patients’ self-assessment showed a significant prevalence of affective disorders in the patients with cardiovascular diseases, who underwent treatment in the Cardiology Department of St. Petersburg Multidisciplinary Hospital. The results demonstrate that cardiac pa tients have personal risk factors for mental disorders development, predominantly anxiety and depressive disorders of neurotic level, both nosogenic and non-nosogenic, which requires a comprehensive psychological, psychotherapeutic and psychiatric care for these patients.


Author(s):  
Enoch Agunanne ◽  
Aamer Abbas ◽  
Debabrata Mukherjee

Background: The lifetime risk of developing Heart Failure (HF) is 20% for Americans ≥40 years of age. In the United States, greater than 650,000 new HF cases are diagnosed annually. About 5.1 million persons in the United States have clinically manifest HF. Additionally, HF has high absolute mortality rates of approximately 50% within 5 years of diagnosis. HF carries substantial health and economic burden. It is the primary diagnosis in >1 million hospitalizations annually. Patients hospitalized for HF are at high risk for all-cause re hospitalization. The total cost of HF care in the United States exceeds $30 billion annually. Objective: The study objective was to investigate the prevalence of valvular heart disease among patients hospitalized for HF in a largely Hispanic population. Methods: This is a retrospective study with aims inclusive of: analyzing the hospitalization and 4 months, 6 months, 2 year- re-hospitalization rates of HF in University Medical Center between Oct 2010 and Oct 2013; evaluating the association between valvular heart disease and hospitalizations for HF. Inclusion criteria were: admission/re hospitalizations with HF (with reduced, preserved and borderline EF). Echocardiographic determination of at least moderate valvular disease was utilized in this study as significant. Exclusion criteria were: patients lost to follow-up, death in hospital, transfer to another acute care facility, and discharge against medical advice. Demographics were also collected. Results: Hospitalizations involving 195 patients (120 men and 75 women) were randomly analyzed. The racial spread showed 77.4% (151 of 195) Hispanics and 22.6% (44 of 195) non-Hispanics. Out of the 195 index hospitalizations, the 4 month, 6 months and 2 years rehospitalization visits were 17.4% (34 of 195), 22.5% (44 of 195) and 38.5% (75 of 195) respectively. The prevalence of significant valvular heart disease was 45.9% (90 of 195), while the prevalence of no valvular heart disease was 54.1% (105 of 195) (p < 0.05). Conclusion: Multiple, prior studies have shown that valvular heart diseases have a comparatively low association with clinical Heart Failure. This study raises a valid point that in some population groups (the Hispanic), the burden of valvular heart disease may be greater than has been published in other groups. This calls for more studies, and has lots of potential implications in Heart Failure management.


2021 ◽  
Vol 10 (1) ◽  
pp. 6-15
Author(s):  
E. V. Samoilova ◽  
M. A. Fatova ◽  
D. R. Mindzaev ◽  
I. V. Zhitareva ◽  
I. V. Zhirov ◽  
...  

Aim. To develop classification criteria for stratifying congestive heart failure (CHF) patients based on the underlying disease.Methods. 61 patients with CHF were recruited in a study. All patients were assigned to three groups according to the underlying disease: patients with coronary artery disease (CAD) (n = 29), patients with arterial hypertension (AH) (n = 19), and those present with dilated cardiomyopathy (DCM) (n = 13). Patients underwent routine clinical examination. Biochemical and inflammatory markers (IL-6, its soluble receptor sIL-6R, and sgp130) were measured in all patients. The Mann-Whitney U test, the Kruskal-Wallis H test, the Pearson χ2 test, and Fischer exact test were used to analyze the selected variables. Discriminant analysis was used for generating prediction models. The quality of the models was evaluated with the ROC analysis.Results. Statistically significant variables identified by the pairwise comparison of patients with CAD and AH, CAD and DCM, AH and DCM were included in the discriminant analysis along with clinically valid parameters. Clinical prediction models of stratifying patients to different etiological groups were based on these parameters. The optimal cut-off values were determined for each model. The area under the ROC curve (AUC) was used to evaluate the quality of the model. The AUC value for CAD and AH groups was 1, for AH and DCM - 72±0.024, and for CAD and DCM - 0.907±0.053.Conclusion. Diagnostic prediction models were developed using the discriminant analysis. These models allow stratifying CHF patients according to the underlying disease (CAD, AH, and DCM). The ROC curves have confirmed the good classifying quality of the models.


2008 ◽  
Vol 389 (3) ◽  
pp. 221-231 ◽  
Author(s):  
Chiao-Po Hsu ◽  
Ibrahim Odewale ◽  
Ralph R. Alcendor ◽  
Junichi Sadoshima

Abstract The prevalence of heart diseases, such as coronary artery disease and congestive heart failure, increases with age. Optimal therapeutic interventions that antagonize aging may reduce the occurrence and mortality of adult heart diseases. We discuss here how molecular mechanisms mediating life span extension affect aging of the heart and its resistance to pathological insults. In particular, we review our recent findings obtained from transgenic mice with cardiac-specific overexpression of Sirt1, which demonstrated delayed aging and protection against oxidative stress in the heart. We propose that activation of known longevity mechanisms in the heart may represent a novel cardioprotection strategy against aging and certain types of cardiac stress, such as oxidative stress.


2017 ◽  
Vol 31 (3) ◽  
pp. 236-240 ◽  
Author(s):  
Dan Li ◽  
Wei Liu ◽  
Dan Ma ◽  
Fengxiang Yun ◽  
Shu Li ◽  
...  

2019 ◽  
Vol 20 (12) ◽  
pp. 1337-1344
Author(s):  
Bernard Cosyns ◽  
Kristina H Haugaa ◽  
Bernhard L Gerber ◽  
Alessia Gimelli ◽  
Erwan Donal ◽  
...  

Abstract European Heart Journal - Cardiovascular Imaging was launched in 2012 as a multimodality cardiovascular imaging journal. It has gained an impressive impact factor during its first 5 years and is now established as one of the top cardiovascular journals and has become the most important cardiovascular imaging journal in Europe. The most important studies from 2018 will be highlighted in two reports. Part I of the review has focused on studies about myocardial function and risk prediction, myocardial ischaemia, and emerging techniques in cardiovascular imaging, while Part II will focus on cardiomyopathies, congenital heart diseases, valvular heart diseases, and heart failure.


Sign in / Sign up

Export Citation Format

Share Document